プラスミノーゲンアクチベーター阻害剤1の世界市場（～2026年）

• 英文タイトル：Global Plasminogen Activator Inhibitor 1 Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY13826 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はプラスミノーゲンアクチベーター阻害剤1のグローバル市場について調査・分析したレポートです。種類別（SK-216、THR-18、デフィブロチドナトリウム、CT-140、その他）市場規模、用途別（血栓症、急性虚血性脳卒中、動脈血栓症、高血圧症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別プラスミノーゲンアクチベーター阻害剤1の競争状況、市場シェア ・世界のプラスミノーゲンアクチベーター阻害剤1市場：種類別市場規模 2015年-2020年（SK-216、THR-18、デフィブロチドナトリウム、CT-140、その他） ・世界のプラスミノーゲンアクチベーター阻害剤1市場：種類別市場規模予測 2021年-2026年（SK-216、THR-18、デフィブロチドナトリウム、CT-140、その他） ・世界のプラスミノーゲンアクチベーター阻害剤1市場：用途別市場規模 2015年-2020年（血栓症、急性虚血性脳卒中、動脈血栓症、高血圧症、その他） ・世界のプラスミノーゲンアクチベーター阻害剤1市場：用途別市場規模予測 2021年-2026年（血栓症、急性虚血性脳卒中、動脈血栓症、高血圧症、その他） ・北米のプラスミノーゲンアクチベーター阻害剤1市場分析：米国、カナダ ・ヨーロッパのプラスミノーゲンアクチベーター阻害剤1市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのプラスミノーゲンアクチベーター阻害剤1市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のプラスミノーゲンアクチベーター阻害剤1市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのプラスミノーゲンアクチベーター阻害剤1市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：D-Pharm Ltd、Jazz Pharmaceuticals Plc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Plasminogen Activator Inhibitor 1 Market
The global Plasminogen Activator Inhibitor 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Plasminogen Activator Inhibitor 1 Scope and Market Size
Plasminogen Activator Inhibitor 1 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Plasminogen Activator Inhibitor 1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Plasminogen Activator Inhibitor 1 market is segmented into
SK-216
THR-18
Defibrotide Sodium
CT-140
Others

Segment by Application, the Plasminogen Activator Inhibitor 1 market is segmented into
Thrombosis
Acute Ischemic Stroke
Arterial Thrombosis
Hypertension
Others

Regional and Country-level Analysis
The Plasminogen Activator Inhibitor 1 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Plasminogen Activator Inhibitor 1 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Plasminogen Activator Inhibitor 1 Market Share Analysis
Plasminogen Activator Inhibitor 1 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Plasminogen Activator Inhibitor 1 business, the date to enter into the Plasminogen Activator Inhibitor 1 market, Plasminogen Activator Inhibitor 1 product introduction, recent developments, etc.

The major vendors covered:
D-Pharm Ltd
Jazz Pharmaceuticals Plc
…

レポート目次

---

1 Study Coverage
1.1 Plasminogen Activator Inhibitor 1 Product Introduction
1.2 Market Segments
1.3 Key Plasminogen Activator Inhibitor 1 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Plasminogen Activator Inhibitor 1 Market Size Growth Rate by Type
1.4.2 SK-216
1.4.3 THR-18
1.4.4 Defibrotide Sodium
1.4.5 CT-140
1.4.6 Others
1.5 Market by Application
1.5.1 Global Plasminogen Activator Inhibitor 1 Market Size Growth Rate by Application
1.5.2 Thrombosis
1.5.3 Acute Ischemic Stroke
1.5.4 Arterial Thrombosis
1.5.5 Hypertension
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Plasminogen Activator Inhibitor 1 Market Size, Estimates and Forecasts
2.1.1 Global Plasminogen Activator Inhibitor 1 Revenue 2015-2026
2.1.2 Global Plasminogen Activator Inhibitor 1 Sales 2015-2026
2.2 Global Plasminogen Activator Inhibitor 1, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Plasminogen Activator Inhibitor 1 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Plasminogen Activator Inhibitor 1 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Plasminogen Activator Inhibitor 1 Competitor Landscape by Players
3.1 Plasminogen Activator Inhibitor 1 Sales by Manufacturers
3.1.1 Plasminogen Activator Inhibitor 1 Sales by Manufacturers (2015-2020)
3.1.2 Plasminogen Activator Inhibitor 1 Sales Market Share by Manufacturers (2015-2020)
3.2 Plasminogen Activator Inhibitor 1 Revenue by Manufacturers
3.2.1 Plasminogen Activator Inhibitor 1 Revenue by Manufacturers (2015-2020)
3.2.2 Plasminogen Activator Inhibitor 1 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Plasminogen Activator Inhibitor 1 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Plasminogen Activator Inhibitor 1 Revenue in 2019
3.2.5 Global Plasminogen Activator Inhibitor 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Plasminogen Activator Inhibitor 1 Price by Manufacturers
3.4 Plasminogen Activator Inhibitor 1 Manufacturing Base Distribution, Product Types
3.4.1 Plasminogen Activator Inhibitor 1 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Plasminogen Activator Inhibitor 1 Product Type
3.4.3 Date of International Manufacturers Enter into Plasminogen Activator Inhibitor 1 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Plasminogen Activator Inhibitor 1 Market Size by Type (2015-2020)
4.1.1 Global Plasminogen Activator Inhibitor 1 Sales by Type (2015-2020)
4.1.2 Global Plasminogen Activator Inhibitor 1 Revenue by Type (2015-2020)
4.1.3 Plasminogen Activator Inhibitor 1 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Plasminogen Activator Inhibitor 1 Market Size Forecast by Type (2021-2026)
4.2.1 Global Plasminogen Activator Inhibitor 1 Sales Forecast by Type (2021-2026)
4.2.2 Global Plasminogen Activator Inhibitor 1 Revenue Forecast by Type (2021-2026)
4.2.3 Plasminogen Activator Inhibitor 1 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Plasminogen Activator Inhibitor 1 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Plasminogen Activator Inhibitor 1 Market Size by Application (2015-2020)
5.1.1 Global Plasminogen Activator Inhibitor 1 Sales by Application (2015-2020)
5.1.2 Global Plasminogen Activator Inhibitor 1 Revenue by Application (2015-2020)
5.1.3 Plasminogen Activator Inhibitor 1 Price by Application (2015-2020)
5.2 Plasminogen Activator Inhibitor 1 Market Size Forecast by Application (2021-2026)
5.2.1 Global Plasminogen Activator Inhibitor 1 Sales Forecast by Application (2021-2026)
5.2.2 Global Plasminogen Activator Inhibitor 1 Revenue Forecast by Application (2021-2026)
5.2.3 Global Plasminogen Activator Inhibitor 1 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Plasminogen Activator Inhibitor 1 by Country
6.1.1 North America Plasminogen Activator Inhibitor 1 Sales by Country
6.1.2 North America Plasminogen Activator Inhibitor 1 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Plasminogen Activator Inhibitor 1 Market Facts & Figures by Type
6.3 North America Plasminogen Activator Inhibitor 1 Market Facts & Figures by Application

7 Europe
7.1 Europe Plasminogen Activator Inhibitor 1 by Country
7.1.1 Europe Plasminogen Activator Inhibitor 1 Sales by Country
7.1.2 Europe Plasminogen Activator Inhibitor 1 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Plasminogen Activator Inhibitor 1 Market Facts & Figures by Type
7.3 Europe Plasminogen Activator Inhibitor 1 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Plasminogen Activator Inhibitor 1 by Region
8.1.1 Asia Pacific Plasminogen Activator Inhibitor 1 Sales by Region
8.1.2 Asia Pacific Plasminogen Activator Inhibitor 1 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Plasminogen Activator Inhibitor 1 Market Facts & Figures by Type
8.3 Asia Pacific Plasminogen Activator Inhibitor 1 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Plasminogen Activator Inhibitor 1 by Country
9.1.1 Latin America Plasminogen Activator Inhibitor 1 Sales by Country
9.1.2 Latin America Plasminogen Activator Inhibitor 1 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Plasminogen Activator Inhibitor 1 Market Facts & Figures by Type
9.3 Central & South America Plasminogen Activator Inhibitor 1 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Plasminogen Activator Inhibitor 1 by Country
10.1.1 Middle East and Africa Plasminogen Activator Inhibitor 1 Sales by Country
10.1.2 Middle East and Africa Plasminogen Activator Inhibitor 1 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Plasminogen Activator Inhibitor 1 Market Facts & Figures by Type
10.3 Middle East and Africa Plasminogen Activator Inhibitor 1 Market Facts & Figures by Application

11 Company Profiles
11.1 D-Pharm Ltd
11.1.1 D-Pharm Ltd Corporation Information
11.1.2 D-Pharm Ltd Description and Business Overview
11.1.3 D-Pharm Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 D-Pharm Ltd Plasminogen Activator Inhibitor 1 Products Offered
11.1.5 D-Pharm Ltd Related Developments
11.2 Jazz Pharmaceuticals Plc
11.2.1 Jazz Pharmaceuticals Plc Corporation Information
11.2.2 Jazz Pharmaceuticals Plc Description and Business Overview
11.2.3 Jazz Pharmaceuticals Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Jazz Pharmaceuticals Plc Plasminogen Activator Inhibitor 1 Products Offered
11.2.5 Jazz Pharmaceuticals Plc Related Developments
11.1 D-Pharm Ltd
11.1.1 D-Pharm Ltd Corporation Information
11.1.2 D-Pharm Ltd Description and Business Overview
11.1.3 D-Pharm Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 D-Pharm Ltd Plasminogen Activator Inhibitor 1 Products Offered
11.1.5 D-Pharm Ltd Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Plasminogen Activator Inhibitor 1 Market Estimates and Projections by Region
12.1.1 Global Plasminogen Activator Inhibitor 1 Sales Forecast by Regions 2021-2026
12.1.2 Global Plasminogen Activator Inhibitor 1 Revenue Forecast by Regions 2021-2026
12.2 North America Plasminogen Activator Inhibitor 1 Market Size Forecast (2021-2026)
12.2.1 North America: Plasminogen Activator Inhibitor 1 Sales Forecast (2021-2026)
12.2.2 North America: Plasminogen Activator Inhibitor 1 Revenue Forecast (2021-2026)
12.2.3 North America: Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2021-2026)
12.3 Europe Plasminogen Activator Inhibitor 1 Market Size Forecast (2021-2026)
12.3.1 Europe: Plasminogen Activator Inhibitor 1 Sales Forecast (2021-2026)
12.3.2 Europe: Plasminogen Activator Inhibitor 1 Revenue Forecast (2021-2026)
12.3.3 Europe: Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Plasminogen Activator Inhibitor 1 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Plasminogen Activator Inhibitor 1 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Plasminogen Activator Inhibitor 1 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Plasminogen Activator Inhibitor 1 Market Size Forecast by Region (2021-2026)
12.5 Latin America Plasminogen Activator Inhibitor 1 Market Size Forecast (2021-2026)
12.5.1 Latin America: Plasminogen Activator Inhibitor 1 Sales Forecast (2021-2026)
12.5.2 Latin America: Plasminogen Activator Inhibitor 1 Revenue Forecast (2021-2026)
12.5.3 Latin America: Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Plasminogen Activator Inhibitor 1 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Plasminogen Activator Inhibitor 1 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Plasminogen Activator Inhibitor 1 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Plasminogen Activator Inhibitor 1 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Plasminogen Activator Inhibitor 1 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Plasminogen Activator Inhibitor 1 Market Segments
Table 2. Ranking of Global Top Plasminogen Activator Inhibitor 1 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Plasminogen Activator Inhibitor 1 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of SK-216
Table 5. Major Manufacturers of THR-18
Table 6. Major Manufacturers of Defibrotide Sodium
Table 7. Major Manufacturers of CT-140
Table 8. Major Manufacturers of Others
Table 9. Global Plasminogen Activator Inhibitor 1 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Plasminogen Activator Inhibitor 1 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Plasminogen Activator Inhibitor 1 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Plasminogen Activator Inhibitor 1 Sales Market Share by Regions (2015-2020)
Table 13. Global Plasminogen Activator Inhibitor 1 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Plasminogen Activator Inhibitor 1 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Plasminogen Activator Inhibitor 1 Sales Share by Manufacturers (2015-2020)
Table 16. Global Plasminogen Activator Inhibitor 1 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Plasminogen Activator Inhibitor 1 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasminogen Activator Inhibitor 1 as of 2019)
Table 18. Plasminogen Activator Inhibitor 1 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Plasminogen Activator Inhibitor 1 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Plasminogen Activator Inhibitor 1 Price (2015-2020) (USD/Pcs)
Table 21. Plasminogen Activator Inhibitor 1 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Plasminogen Activator Inhibitor 1 Product Type
Table 23. Date of International Manufacturers Enter into Plasminogen Activator Inhibitor 1 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Plasminogen Activator Inhibitor 1 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Plasminogen Activator Inhibitor 1 Sales Share by Type (2015-2020)
Table 27. Global Plasminogen Activator Inhibitor 1 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Plasminogen Activator Inhibitor 1 Revenue Share by Type (2015-2020)
Table 29. Plasminogen Activator Inhibitor 1 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Plasminogen Activator Inhibitor 1 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Plasminogen Activator Inhibitor 1 Sales Share by Application (2015-2020)
Table 32. North America Plasminogen Activator Inhibitor 1 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Plasminogen Activator Inhibitor 1 Sales Market Share by Country (2015-2020)
Table 34. North America Plasminogen Activator Inhibitor 1 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Plasminogen Activator Inhibitor 1 Revenue Market Share by Country (2015-2020)
Table 36. North America Plasminogen Activator Inhibitor 1 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Plasminogen Activator Inhibitor 1 Sales Market Share by Type (2015-2020)
Table 38. North America Plasminogen Activator Inhibitor 1 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Plasminogen Activator Inhibitor 1 Sales Market Share by Application (2015-2020)
Table 40. Europe Plasminogen Activator Inhibitor 1 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Plasminogen Activator Inhibitor 1 Sales Market Share by Country (2015-2020)
Table 42. Europe Plasminogen Activator Inhibitor 1 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Plasminogen Activator Inhibitor 1 Revenue Market Share by Country (2015-2020)
Table 44. Europe Plasminogen Activator Inhibitor 1 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Plasminogen Activator Inhibitor 1 Sales Market Share by Type (2015-2020)
Table 46. Europe Plasminogen Activator Inhibitor 1 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Plasminogen Activator Inhibitor 1 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Plasminogen Activator Inhibitor 1 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Plasminogen Activator Inhibitor 1 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Plasminogen Activator Inhibitor 1 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Plasminogen Activator Inhibitor 1 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Plasminogen Activator Inhibitor 1 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Plasminogen Activator Inhibitor 1 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Plasminogen Activator Inhibitor 1 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Plasminogen Activator Inhibitor 1 Sales Market Share by Application (2015-2020)
Table 56. Latin America Plasminogen Activator Inhibitor 1 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Plasminogen Activator Inhibitor 1 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Plasminogen Activator Inhibitor 1 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Plasminogen Activator Inhibitor 1 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Plasminogen Activator Inhibitor 1 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Plasminogen Activator Inhibitor 1 Sales Market Share by Type (2015-2020)
Table 62. Latin America Plasminogen Activator Inhibitor 1 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Plasminogen Activator Inhibitor 1 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Plasminogen Activator Inhibitor 1 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Plasminogen Activator Inhibitor 1 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Market Share by Application (2015-2020)
Table 72. D-Pharm Ltd Corporation Information
Table 73. D-Pharm Ltd Description and Major Businesses
Table 74. D-Pharm Ltd Plasminogen Activator Inhibitor 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. D-Pharm Ltd Product
Table 76. D-Pharm Ltd Recent Development
Table 77. Jazz Pharmaceuticals Plc Corporation Information
Table 78. Jazz Pharmaceuticals Plc Description and Major Businesses
Table 79. Jazz Pharmaceuticals Plc Plasminogen Activator Inhibitor 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Jazz Pharmaceuticals Plc Product
Table 81. Jazz Pharmaceuticals Plc Recent Development
Table 82. Global Plasminogen Activator Inhibitor 1 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 83. Global Plasminogen Activator Inhibitor 1 Sales Market Share Forecast by Regions (2021-2026)
Table 84. Global Plasminogen Activator Inhibitor 1 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 85. Global Plasminogen Activator Inhibitor 1 Revenue Market Share Forecast by Regions (2021-2026)
Table 86. North America: Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 87. North America: Plasminogen Activator Inhibitor 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 88. Europe: Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 89. Europe: Plasminogen Activator Inhibitor 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 90. Asia Pacific: Plasminogen Activator Inhibitor 1 Sales Forecast by Region (2021-2026) (K Pcs)
Table 91. Asia Pacific: Plasminogen Activator Inhibitor 1 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 92. Latin America: Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 93. Latin America: Plasminogen Activator Inhibitor 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 94. Middle East and Africa: Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 95. Middle East and Africa: Plasminogen Activator Inhibitor 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 96. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 97. Key Challenges
Table 98. Market Risks
Table 99. Main Points Interviewed from Key Plasminogen Activator Inhibitor 1 Players
Table 100. Plasminogen Activator Inhibitor 1 Customers List
Table 101. Plasminogen Activator Inhibitor 1 Distributors List
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasminogen Activator Inhibitor 1 Product Picture
Figure 2. Global Plasminogen Activator Inhibitor 1 Sales Market Share by Type in 2020 & 2026
Figure 3. SK-216 Product Picture
Figure 4. THR-18 Product Picture
Figure 5. Defibrotide Sodium Product Picture
Figure 6. CT-140 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Plasminogen Activator Inhibitor 1 Sales Market Share by Application in 2020 & 2026
Figure 9. Thrombosis
Figure 10. Acute Ischemic Stroke
Figure 11. Arterial Thrombosis
Figure 12. Hypertension
Figure 13. Others
Figure 14. Plasminogen Activator Inhibitor 1 Report Years Considered
Figure 15. Global Plasminogen Activator Inhibitor 1 Market Size 2015-2026 (US$ Million)
Figure 16. Global Plasminogen Activator Inhibitor 1 Sales 2015-2026 (K Pcs)
Figure 17. Global Plasminogen Activator Inhibitor 1 Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Plasminogen Activator Inhibitor 1 Sales Market Share by Region (2015-2020)
Figure 19. Global Plasminogen Activator Inhibitor 1 Sales Market Share by Region in 2019
Figure 20. Global Plasminogen Activator Inhibitor 1 Revenue Market Share by Region (2015-2020)
Figure 21. Global Plasminogen Activator Inhibitor 1 Revenue Market Share by Region in 2019
Figure 22. Global Plasminogen Activator Inhibitor 1 Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Plasminogen Activator Inhibitor 1 Revenue in 2019
Figure 24. Plasminogen Activator Inhibitor 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Plasminogen Activator Inhibitor 1 Sales Market Share by Type (2015-2020)
Figure 26. Global Plasminogen Activator Inhibitor 1 Sales Market Share by Type in 2019
Figure 27. Global Plasminogen Activator Inhibitor 1 Revenue Market Share by Type (2015-2020)
Figure 28. Global Plasminogen Activator Inhibitor 1 Revenue Market Share by Type in 2019
Figure 29. Global Plasminogen Activator Inhibitor 1 Market Share by Price Range (2015-2020)
Figure 30. Global Plasminogen Activator Inhibitor 1 Sales Market Share by Application (2015-2020)
Figure 31. Global Plasminogen Activator Inhibitor 1 Sales Market Share by Application in 2019
Figure 32. Global Plasminogen Activator Inhibitor 1 Revenue Market Share by Application (2015-2020)
Figure 33. Global Plasminogen Activator Inhibitor 1 Revenue Market Share by Application in 2019
Figure 34. North America Plasminogen Activator Inhibitor 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Plasminogen Activator Inhibitor 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Plasminogen Activator Inhibitor 1 Sales Market Share by Country in 2019
Figure 37. North America Plasminogen Activator Inhibitor 1 Revenue Market Share by Country in 2019
Figure 38. U.S. Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Plasminogen Activator Inhibitor 1 Market Share by Type in 2019
Figure 43. North America Plasminogen Activator Inhibitor 1 Market Share by Application in 2019
Figure 44. Europe Plasminogen Activator Inhibitor 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Plasminogen Activator Inhibitor 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Plasminogen Activator Inhibitor 1 Sales Market Share by Country in 2019
Figure 47. Europe Plasminogen Activator Inhibitor 1 Revenue Market Share by Country in 2019
Figure 48. Germany Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Plasminogen Activator Inhibitor 1 Market Share by Type in 2019
Figure 59. Europe Plasminogen Activator Inhibitor 1 Market Share by Application in 2019
Figure 60. Asia Pacific Plasminogen Activator Inhibitor 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Plasminogen Activator Inhibitor 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Plasminogen Activator Inhibitor 1 Sales Market Share by Region in 2019
Figure 63. Asia Pacific Plasminogen Activator Inhibitor 1 Revenue Market Share by Region in 2019
Figure 64. China Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Plasminogen Activator Inhibitor 1 Market Share by Type in 2019
Figure 87. Asia Pacific Plasminogen Activator Inhibitor 1 Market Share by Application in 2019
Figure 88. Latin America Plasminogen Activator Inhibitor 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Plasminogen Activator Inhibitor 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Plasminogen Activator Inhibitor 1 Sales Market Share by Country in 2019
Figure 91. Latin America Plasminogen Activator Inhibitor 1 Revenue Market Share by Country in 2019
Figure 92. Mexico Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Plasminogen Activator Inhibitor 1 Market Share by Type in 2019
Figure 99. Latin America Plasminogen Activator Inhibitor 1 Market Share by Application in 2019
Figure 100. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Plasminogen Activator Inhibitor 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Plasminogen Activator Inhibitor 1 Revenue Market Share by Country in 2019
Figure 104. Turkey Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Plasminogen Activator Inhibitor 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Plasminogen Activator Inhibitor 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Plasminogen Activator Inhibitor 1 Market Share by Type in 2019
Figure 111. Middle East and Africa Plasminogen Activator Inhibitor 1 Market Share by Application in 2019
Figure 112. North America Plasminogen Activator Inhibitor 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Plasminogen Activator Inhibitor 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Plasminogen Activator Inhibitor 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Plasminogen Activator Inhibitor 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Plasminogen Activator Inhibitor 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Plasminogen Activator Inhibitor 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Plasminogen Activator Inhibitor 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Plasminogen Activator Inhibitor 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Plasminogen Activator Inhibitor 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed

---